WebOct 10, 2024 · October 31, 2024 updated by: Changchun Intellicrown Pharmaceutical Co. LTD Phase I Clinical Study of Safety,Tolerability, Pharmacokinetics and … WebAbstract: The present disclosure relates to primer and probe sets for pathogen detection of infection in a transplant patient, a kit and use thereof, and belongs to the technical field of molecular biology detection. There are 23 primer and probe sets that can be used to jointly detect 23 kinds of pathogens with a high infection rate and a high lethality rate after …
Changchun Wancheng Bio-Electron Co., LTD. LinkedIn
WebClinical Trials Sponsored by Changchun Intellicrown Pharmaceutical Co. LTD . Total 2 results. NCT04412616. Recruiting. ZZ06 in Adult Patients With Advanced EGFR Positive … WebApr 21, 2024 · Changchun Intellicrown Pharmaceutical Co., Ltd, No.1688 Jichang Road, Changchun, 130507, Jilin, People’s Republic of China. Xin Zhang & Xitian Zhang baud merch
Phase I Study of KN044 in Locally Advanced/Metastatic …
WebMay 14, 2024 · Changchun Intellicrown Pharmaceutical Co. LTD 9 March 2024 First Received: May 14, 2024 Last Updated: March 9, 2024 Phase: Phase 1 Start Date: September 1, 2024 http://www.cdek.liu.edu/org/56486/ WebWe're an emerging biopharmaceutical company focusing on novel therapeutic approaches based on the pharmacologic manipulations of P2 receptors' signal transductions activated by extracellular adenosine 5'-triphosphate (ATP).Our lead drug-candidate DT-0111 is a small, water soluble, selective P 2X2/3 R antagonist that is being developed for the … baudner